fg 5893 has been researched along with Depression in 1 studies
*Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albinsson, A; Andersson, G; Björk, A; Klint, T; Svartengren, J | 1 |
1 other study(ies) available for fg 5893 and Depression
Article | Year |
---|---|
Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Avoidance Learning; Behavior, Animal; Body Temperature; Brain; Brain Chemistry; Corticosterone; Depression; In Vitro Techniques; Male; Nicotinic Acids; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Swimming; Vocalization, Animal | 1994 |